EDRH
AGN

Edmond de Rothschild Holding’s Allergan plc AGN Stock Holding History

Edmond de Rothschild Holding’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-20,000
Closed -$4K – 758
2018
Q3 		$4K Hold
20,000
– – ﹤0.01% 723
2018
Q2 		$4K Hold
20,000
– – ﹤0.01% 725
2018
Q1 		$7K Hold
20,000
– – ﹤0.01% 742
2017
Q4 		$19K Hold
20,000
– – ﹤0.01% 718
2017
Q3 		$112K Buy
20,000
+3,000
+18% +$698K ﹤0.01% 569
2017
Q2 		$151K Hold
17,000
– – ﹤0.01% 516
2017
Q1 		$223K Hold
17,000
– – 0.01% 472
2016
Q4 		$169K Hold
17,000
– – ﹤0.01% 512
2016
Q3 		$350K Hold
17,000
– – 0.01% 440
2016
Q2 		$401K Buy
+17,000
New +$3.92M 0.01% 409

Other funds holding AGN

AJ
Ashburton (Jersey) St Helier, Jersey $227M AUM
C
Cerebellum San Francisco, California $21.5M AUM
B
Barings Charlotte, North Carolina $5.64B AUM 18.33% 1-Year Est. Return
JJ
JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return
VFA
Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return
OPS
Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Edmond de Rothschild Holding's AGN Position: Q2 2020 in Review

Edmond de Rothschild Holding sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 5,830 shares — an estimated $1.03M sold.

Edmond de Rothschild Holding first reported a position in AGN in Q2 2015 and held it in 20 quarters. The position peaked at $125M in Q1 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Edmond de Rothschild Holding reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Edmond de Rothschild Holding sold 5,830 Allergan plc shares in Q2 2020, an estimated $1.03M.
  • Edmond de Rothschild Holding first reported a position in Allergan plc in Q2 2015 and held it in 20 quarters.
  • Edmond de Rothschild Holding's Allergan plc position peaked at $125M in Q1 2017.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Edmond de Rothschild Holding's 13F filing for Q2 2020, filed 7 Aug 2020.